ATE242806T1 - Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen - Google Patents
Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungenInfo
- Publication number
- ATE242806T1 ATE242806T1 AT93924946T AT93924946T ATE242806T1 AT E242806 T1 ATE242806 T1 AT E242806T1 AT 93924946 T AT93924946 T AT 93924946T AT 93924946 T AT93924946 T AT 93924946T AT E242806 T1 ATE242806 T1 AT E242806T1
- Authority
- AT
- Austria
- Prior art keywords
- relocation
- related applications
- cyclin complex
- pertains
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4739—Cyclin; Prad 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96330892A | 1992-10-16 | 1992-10-16 | |
US99199792A | 1992-12-17 | 1992-12-17 | |
PCT/US1993/009945 WO1994009135A1 (en) | 1992-10-16 | 1993-10-18 | Cyclin complex rearrangement and uses related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE242806T1 true ATE242806T1 (de) | 2003-06-15 |
Family
ID=27130450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93924946T ATE242806T1 (de) | 1992-10-16 | 1993-10-18 | Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0665886B1 (de) |
JP (1) | JP3485186B2 (de) |
KR (1) | KR100331363B1 (de) |
AT (1) | ATE242806T1 (de) |
AU (1) | AU687764B2 (de) |
CA (1) | CA2146965C (de) |
DE (1) | DE69333043T2 (de) |
DK (1) | DK0665886T3 (de) |
ES (1) | ES2201064T3 (de) |
PT (1) | PT665886E (de) |
WO (1) | WO1994009135A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889169A (en) * | 1991-05-16 | 1999-03-30 | Cold Spring Harbor Laboratory | Cell cycle regulatory protein p16 gene |
US7550561B1 (en) | 1991-05-16 | 2009-06-23 | Cold Spring Harbor Laboratory | p16INK4 polypeptides |
WO1995006415A1 (en) * | 1993-08-30 | 1995-03-09 | Baylor College Of Medicine | Senescent cell-derived inhibitors of dna synthesis |
US6372249B1 (en) | 1991-12-16 | 2002-04-16 | Baylor College Of Medicine | Senscent cell-derived inhibitors of DNA synthesis |
US5596079A (en) * | 1991-12-16 | 1997-01-21 | Smith; James R. | Mimetics of senescent cell derived inhibitors of DNA synthesis |
US5962316A (en) * | 1992-10-16 | 1999-10-05 | Cold Spring Harbor Laboratory | Cell-cycle regulatory proteins, and uses related thereto |
US6211334B1 (en) * | 1992-10-16 | 2001-04-03 | Cold Spring Harbor | Cell-cycle regulatory proteins, and uses related thereto |
US6331390B1 (en) | 1992-12-17 | 2001-12-18 | Cold Spring Harbor Laboratory | Cell-cycle regulatory proteins, and uses related thereto |
US6043030A (en) * | 1992-12-17 | 2000-03-28 | Cold Spring Harbor Laboratory | Cell-cycle regulatory proteins, and uses related thereto |
US7691632B2 (en) | 1993-11-18 | 2010-04-06 | Cold Spring Harbor Laboratory | Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression |
US5989815A (en) * | 1994-03-18 | 1999-11-23 | University Of Utah Research Foundation | Methods for detecting predisposition to cancer at the MTS gene |
AU685627B2 (en) * | 1994-03-18 | 1998-01-22 | Myriad Genetics, Inc. | Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene |
NZ283539A (en) * | 1994-03-18 | 1998-02-26 | Myriad Genetics Inc | Multiple tumour suppressor (mts) gene, probes, use in diagnosis and treatment of cancer |
US6689561B1 (en) * | 1994-04-14 | 2004-02-10 | The Regents Of The University Of California | Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
ATE283355T1 (de) * | 1994-05-24 | 2004-12-15 | Baylor College Medicine | Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese |
EP0775206A1 (de) * | 1994-07-22 | 1997-05-28 | Novartis AG | Duales hybridsystem |
GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
US5843756A (en) * | 1995-06-07 | 1998-12-01 | Myriad Genetics, Inc. | Mouse MTSI gene |
GB9509557D0 (en) | 1995-05-11 | 1995-07-05 | Univ Dundee | PCNA binding substance |
JPH11510380A (ja) | 1995-07-17 | 1999-09-14 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | p16発現構築物および癌治療におけるその適用 |
US7163925B1 (en) | 1995-07-17 | 2007-01-16 | Board Of Regents, The University Of Texas System | p16 expression constructs and their application in cancer therapy |
US5981702A (en) * | 1995-09-21 | 1999-11-09 | Cold Spring Harbor Laboratory | Cyclin/CDK associated proteins, and uses related thereto |
GB9519275D0 (en) | 1995-09-21 | 1995-11-22 | Univ Dundee | Substances and their therapeutic use |
US7087582B1 (en) | 1995-09-26 | 2006-08-08 | Regents Of The University Of Michigan | Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21 |
US5863904A (en) * | 1995-09-26 | 1999-01-26 | The University Of Michigan | Methods for treating cancers and restenosis with P21 |
DE69634044T2 (de) | 1995-10-05 | 2005-12-08 | Sumitomo Electric Industries, Ltd. | Menschliches Cyclin I und das dafür codierende Gen |
US5672508A (en) * | 1996-01-23 | 1997-09-30 | Mitotix, Inc. | Inhibitors of cell-cycle progression, and uses related thereto |
ATE333465T1 (de) | 1996-05-08 | 2006-08-15 | Cyclacel Ltd | Methoden und mittel zur hemmung der cdk4- aktivität |
AU741712B2 (en) * | 1998-02-18 | 2001-12-06 | Theryte Limited | Treating cancer |
US6489305B1 (en) | 1998-05-08 | 2002-12-03 | Canji, Inc. | Methods and compositions for the treatment of ocular diseases |
DE19829473C2 (de) | 1998-07-01 | 2000-08-10 | Magnus Von Knebel Doeberitz Ch | Verfahren zur frühen Diagnose von Carcinomen |
KR20000019888A (ko) * | 1998-09-16 | 2000-04-15 | 성재갑 | 곤충세포를 이용한 cdk4/hc△p16 복합체의 제조방법 및이로부터 cdk4 단백질의 정제방법 |
KR20000038917A (ko) * | 1998-12-10 | 2000-07-05 | 성재갑 | 곤충세포를 이용한 cdk6/p16 복합체의 제조방법 |
AU2004293474B2 (en) | 2003-11-24 | 2010-12-23 | Canji, Inc. | Reduction of dermal scarring |
CA2576159A1 (en) | 2004-08-27 | 2006-03-02 | Cyclacel Limited | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
-
1993
- 1993-10-18 DE DE69333043T patent/DE69333043T2/de not_active Expired - Lifetime
- 1993-10-18 DK DK93924946T patent/DK0665886T3/da active
- 1993-10-18 PT PT93924946T patent/PT665886E/pt unknown
- 1993-10-18 KR KR1019950701512A patent/KR100331363B1/ko not_active IP Right Cessation
- 1993-10-18 AT AT93924946T patent/ATE242806T1/de not_active IP Right Cessation
- 1993-10-18 JP JP51032894A patent/JP3485186B2/ja not_active Expired - Lifetime
- 1993-10-18 EP EP93924946A patent/EP0665886B1/de not_active Expired - Lifetime
- 1993-10-18 AU AU54440/94A patent/AU687764B2/en not_active Expired
- 1993-10-18 ES ES93924946T patent/ES2201064T3/es not_active Expired - Lifetime
- 1993-10-18 CA CA002146965A patent/CA2146965C/en not_active Expired - Lifetime
- 1993-10-18 WO PCT/US1993/009945 patent/WO1994009135A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0665886B1 (de) | 2003-06-11 |
WO1994009135A1 (en) | 1994-04-28 |
DK0665886T3 (da) | 2003-10-06 |
EP0665886A1 (de) | 1995-08-09 |
CA2146965C (en) | 2003-07-29 |
AU687764B2 (en) | 1998-03-05 |
DE69333043D1 (de) | 2003-07-17 |
KR100331363B1 (ko) | 2002-12-05 |
AU5444094A (en) | 1994-05-09 |
ES2201064T3 (es) | 2004-03-16 |
PT665886E (pt) | 2003-10-31 |
JPH08502649A (ja) | 1996-03-26 |
JP3485186B2 (ja) | 2004-01-13 |
KR950704483A (ko) | 1995-11-20 |
DE69333043T2 (de) | 2004-05-06 |
CA2146965A1 (en) | 1994-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE242806T1 (de) | Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen | |
Greenwald | Handbook methods for oxygen radical research | |
NZ505847A (en) | Adenylate kinase assay for rapid and sensitive investigation of bacterial growth and inhibition | |
BRPI9912227A (pt) | método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método. | |
AU5419399A (en) | Method for determining the immune defences of blood, test kit therefor and use of a suitable system for taking blood samples | |
DE69427103D1 (de) | Verfahren, Reagenzien und Kits zur Untersuchung von Neisseria gonorrhoeae und Chlamydia trachomatis | |
DE59109048D1 (de) | Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben | |
AU3847100A (en) | Method and kitset for sampling and storage of biological samples | |
DE60024092D1 (de) | Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis | |
Feoktistova et al. | Techniques to distinguish apoptosis from necroptosis | |
ATE318930T1 (de) | Nukleinsäuresonden zur detektion von candida- spezies | |
NO952811D0 (no) | Påvisning av bencelleaktivitet | |
Sagan et al. | Spacecraft sterilization standards and contamination of Mars | |
DE69032329D1 (de) | Für c.difficile spezifische oligonukleotide | |
ATE114817T1 (de) | Immunologisches nachweisverfahren für herbizide. | |
BRPI0016249B8 (pt) | utilização de um substrato cromogênico e composição que permite a detecção de pelo menos uma cepa e/ou uma espécie de microorganismos. | |
PT1220950E (pt) | Marcadores geneticos da toxicidade preparacao e utilizacao | |
Zeevi et al. | In vitro immunosuppressive effects of FK506 in combination with other drugs | |
NO975968L (no) | Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer | |
TR199902757T2 (xx) | Grup O HIV-1 vir�slerine ba�l� enfeksiyonlar�n tespiti i�in biyolojik testlerde kullan�labilen sentetik peptitler. | |
Inai et al. | Chiral interaction in peptide molecules: Effects of chiral peptide species on helix‐sense induction in an N‐terminal‐free achiral peptide | |
Jarcho | An early medicostatistical map (Malgaigne, 1840). | |
Rust et al. | An uncommon cause for a common complaint | |
Kozakiewicz et al. | Quantitative testing and thermography in carpal tunnel syndrome | |
Sharma et al. | Determination Of PGM, EsD, GLO (1) and EAP Polymorphs from Human Dental Pulp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0665886 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |